A Study to Evaluate the Bioavailability of Risankizumab in Pre-filled Syringe or Auto-injector in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

226

Participants

Timeline

Start Date

April 2, 2019

Primary Completion Date

November 11, 2019

Study Completion Date

November 11, 2019

Conditions

Healthy Volunteers

Interventions

DRUG

Risankizumab

Subcutaneous Injection via Prefilled Syringe (PFS)

DRUG

Risankizumab

Subcutaneous Injection via Auto-Injector (AI)

Trial Locations (2)

Acpru /Id# 210844, Grayslake

PPD Clinical Research Unit - Austin /ID# 211456, Austin